Fulgent Genetics (FLGT) Financials: Revenue & Earnings

FLGT price $21.09 +0.39 +1.88%

Ticker
FLGT
Price
$21.09
Change
+0.39 +1.88%
Market cap ?
$580.30M
P/E ?
-7.19
Dividend yield ?
0.00%
Beta ?
0.93
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
40
Value
59
Quality
32
Growth
29

Stocklytics score rationale: value 59, quality 32, growth 29.

Financials

2016201720182019202020212022202320242025
18276000187300002135700032528000421712000992584000618968000289213000283470000322671000

Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally. Their diverse array of genetic tests covers a wide range of applications, including extensive oncology panels and solid tumor molecular profiling for cancer identification, Beacon carrier screening for inherited…

Fair value

FLGT fair value $114.19. Price $21.09. Price is 82% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 76% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 79.67M. Growth 2.80%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.43% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 27.52M. Net debt -42.52M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare FLGT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.65—86.30M
2026-07-30-0.58-0.4685.39M94.00M
2026-05-01-0.36-0.3571.14M68.09M
2026-02-270.160.0383.34M85.38M
2025-11-070.14-0.2484.07M85.38M
2025-08-010.07-0.2381.80M81.43M
2025-05-020.04-0.1973.46M76.98M
2025-02-280.04-0.3176.21M75.39M
2024-11-080.31-0.1971.74M75.39M
2024-08-020.15-0.3171.03M69.07M
2024-05-03-0.01-0.3364.48M65.36M
2024-02-280.28-0.3070.50M66.32M
2023-11-03-0.39-0.3384.69M67.14M
2023-08-04-0.08-0.3367.85M62.48M
2023-05-05-0.22-0.4566.17M60.05M
2023-02-28-0.48-0.5667.70M59.57M
2022-11-070.320.17105.66M91.36M
2022-08-040.780.73125.34M122.70M
2022-05-035.083.86320.27M270.85M
2022-02-233.342.61251.67M191.10M
2021-11-093.953.25227.87M131.96M
2021-08-092.472.76153.62M153.62M
2021-05-066.595.86359.43M318.95M
2021-03-046.204.05294.98M—
2020-11-092.080.55101.72M163.12M
2020-08-040.170.0117.27M2.03M
2020-05-04-0.03-0.017.75M5.17M
2020-03-100.040.068.39M8.39M
2019-11-040.140.0310.35M2.22M
2019-08-050.06—8.42M—
2019-05-07-0.06-0.025.37M1.79M
2019-02-28-0.01-0.015.68M5.67M
2018-11-06-0.03-0.025.62M4.64M
2018-08-06-0.01-0.015.40M16.20M
2018-05-07-0.06-0.044.65M3.10M
2018-02-28-0.06-0.014.28M713.50K
2017-11-06-0.02-0.014.50M4.50M
2017-08-070.020.024.64M4.64M
2017-05-080.030.055.31M8.84M
2017-02-270.060.045.85M3.90M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-02Gao HanlinSell1.67K$19.6632.89K
2026-09-02Xie JianSell2.13K$19.6641.81K
2026-09-01Kim PaulSell2.09K$19.5940.88K
2026-09-01Hsieh MingSell4.39K$19.5986.04K
2026-08-27Xie JianSell1.19K$19.9123.75K
2026-08-27Gao HanlinSell939$19.9118.69K
2026-08-26Hsieh MingSell2.95K$19.8158.42K
2026-08-26Kim PaulSell1.17K$19.8123.14K
2026-07-26Kim PaulSell2.75K$19.6754.03K
2026-07-26Xie JianSell4.36K$19.6785.78K
2026-07-26Gao HanlinSell1.65K$19.6732.36K
2026-05-27Xie JianSell1.20K$17.6021.14K
2026-05-27Gao HanlinSell945$17.6016.63K
2026-05-26Kim PaulSell1.17K$17.6720.64K
2026-05-26Hsieh MingSell2.95K$17.6752.11K
2026-05-14Nohaile MichaelBuy5.56K——
2026-05-14Nohaile MichaelBuy8.43K$16.19136.42K
2026-05-14Dong LindaBuy11.12K——
2026-05-14GROVES REGINA EBuy11.12K——
2026-04-26Gao HanlinSell1.65K$16.3126.83K
2026-04-26Xie JianSell4.36K$16.3171.13K
2026-04-26Kim PaulSell2.75K$16.3144.80K
2026-03-09Hsieh MingSell750.00K——
2026-03-01Xie JianSell1.08K$15.3316.54K
2026-03-01Xie JianSell8.15K$15.33124.89K
2026-03-01Kim PaulSell1.13K$15.3317.37K
2026-03-01Kim PaulSell8.35K$15.33127.96K
2026-03-01Gao HanlinSell1.02K$15.3315.61K
2026-03-01Gao HanlinSell6.41K$15.3398.27K
2026-03-01Hsieh MingSell17.57K$15.33269.29K
2026-02-26Xie JianSell1.14K$24.7628.23K
2026-02-26Kim PaulSell1.17K$24.7628.92K
2026-02-26Gao HanlinSell897$24.7622.21K
2026-02-26Hsieh MingSell2.95K$24.7673.02K
2026-02-24Kim PaulBuy31.18K——
2026-02-24Kim PaulBuy26.67K——
2026-02-24Kim PaulSell3.24K$23.0974.83K
2026-02-24Kim PaulSell8.46K$23.09195.25K
2026-02-24Kim PaulBuy14.93K——
2026-02-24Kim PaulSell15.10K$23.09348.54K
2026-02-24Kim PaulBuy5.72K——
2026-02-24Xie JianBuy31.96K——
2026-02-24Xie JianBuy27.34K——
2026-02-24Xie JianSell3.16K$23.0973.03K
2026-02-24Xie JianSell8.25K$23.09190.58K
2026-02-24Xie JianSell14.75K$23.09340.60K
2026-02-24Xie JianBuy15.30K——
2026-02-24Xie JianBuy5.86K——
2026-02-24Gao HanlinBuy26.66K——
2026-02-24Gao HanlinBuy22.81K——
2026-02-24Gao HanlinSell2.49K$23.0957.47K
2026-02-24Gao HanlinSell4.66K$23.09107.62K
2026-02-24Gao HanlinSell8.15K$23.09188.16K
2026-02-24Gao HanlinBuy12.76K——
2026-02-24Gao HanlinBuy4.89K——
2026-02-24Hsieh MingBuy69.29K——
2026-02-24Hsieh MingBuy59.28K——
2026-02-24Hsieh MingSell10.23K$23.09236.21K
2026-02-24Hsieh MingSell21.35K$23.09493.06K
2026-02-24Hsieh MingBuy39.80K——
2026-02-24Hsieh MingSell31.76K$23.09733.34K
2026-02-24Hsieh MingBuy19.07K——
2026-02-23Kim PaulSell661$23.0115.21K
2026-02-23Xie JianSell655$23.0115.07K
2026-02-23Gao HanlinSell403$23.019.27K
2026-02-23Hsieh MingSell2.17K$23.0149.86K
2026-01-26Gao HanlinSell1.33K$27.5336.64K
2026-01-26Xie JianSell4.71K$27.53129.69K
2026-01-26Kim PaulSell3.00K$27.5382.70K
2025-12-02Xie JianSell1.14K$28.3332.30K
2025-12-02Gao HanlinSell1.07K$28.3330.46K
2025-12-01Kim PaulSell1.13K$28.5232.26K
2025-11-28Xie JianSell1.20K$29.5735.42K
2025-11-28Gao HanlinSell943$29.5727.88K
2025-11-26Kim PaulSell1.17K$30.1535.15K
2025-11-26Hsieh MingSell2.94K$30.1588.76K
2025-11-24Xie JianSell681$30.4720.75K
2025-11-24Gao HanlinSell535$30.4716.30K
2025-11-23Hsieh MingSell2.12K$30.0063.48K
2025-11-23Kim PaulSell671$30.0020.13K
2025-11-19Xie JianSell10.00K$29.10290.98K
2025-11-19Xie JianSell10.00K——
2025-10-26Gao HanlinSell1.64K$23.7438.98K
2025-10-26Kim PaulSell2.74K$23.7465.12K
2025-10-26Xie JianSell4.35K$23.74103.34K
2025-09-03Gao HanlinSell1.06K$22.0323.41K
2025-09-03Xie JianSell1.13K$22.0324.85K
2025-09-01Kim PaulSell1.13K$22.1725.07K
2025-08-27Xie JianSell1.20K$21.4825.76K
2025-08-27Gao HanlinSell943$21.4820.26K
2025-08-26Hsieh MingSell2.94K$21.4763.21K
2025-08-26Kim PaulSell1.17K$21.4725.03K
2025-08-25Xie JianSell696$21.5014.97K
2025-08-25Gao HanlinSell548$21.5011.78K
2025-08-23Hsieh MingSell2.12K$21.7746.04K
2025-08-23Kim PaulSell670$21.7714.59K
2025-08-01Hsieh MingSell1.34K$18.5324.81K
2025-07-26Kim PaulSell2.74K$18.3750.39K
2025-07-26Xie JianSell4.35K$18.3779.95K
2025-07-26Gao HanlinSell1.64K$18.3730.16K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 147, holders -15 vs prior quarter. Ownership 51.97%.

HolderSharesChangeChange %Value
BLACKROCK, INC.2.29M-487.85K-17.58%46.92M
ACADIAN ASSET MANAGEMENT LLC1.02M-216.04K-17.51%20.87M
VANGUARD CAPITAL MANAGEMENT LLC789.50K-90.65K-10.30%16.20M
JACOBS LEVY EQUITY MANAGEMENT, INC782.12K425.76K+119.47%16.05M
JPMORGAN CHASE & CO756.56K296.19K+64.34%15.53M
DIAMETRIC CAPITAL, LP697.78K336.74K+93.27%14.32M
AMERIPRISE FINANCIAL INC670.08K106.71K+18.94%13.75M
DIMENSIONAL FUND ADVISORS LP625.36K-46.31K-6.89%12.83M
GEODE CAPITAL MANAGEMENT, LLC521.01K-63.19K-10.82%10.69M
STATE STREET CORP498.67K-30.73K-5.80%10.23M
INVENOMIC CAPITAL MANAGEMENT LP498.29K-112.03K-18.36%10.22M
TWO SIGMA INVESTMENTS, LP400.99K78.80K+24.46%8.23M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.350.99K350.99KNew7.20M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC350.99K-3.20K-0.90%7.20M
MILLENNIUM MANAGEMENT LLC320.91K-80.91K-20.14%6.59M
GOLDMAN SACHS GROUP INC307.94K-3.48K-1.12%6.32M
D. E. SHAW & CO., INC.292.01K-194.76K-40.01%5.99M
HRT FINANCIAL LP229.44K183.00K+393.98%4.71M
PEAPOD LANE CAPITAL LLC224.21K3.58K+1.62%4.60M
POINT72 ASSET MANAGEMENT, L.P.211.71K211.71KNew4.34M
MEDINA VALUE PARTNERS, LLC193.06K22.99K+13.52%3.96M
VANGUARD PORTFOLIO MANAGEMENT LLC186.31K-29.54K-13.69%3.82M
BANK OF AMERICA CORP /DE/175.58K55.00K+45.61%3.60M
UBS GROUP AG174.95K-65.81K-27.33%3.59M
CITADEL ADVISORS LLC174.18K163.98K+1607.65%3.57M

Earnings and financials

Fulgent Genetics, Inc. (FLGT) trades at $21.09, with a market cap of $580.30M and a trailing P/E of -7.19. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
18276000187300002135700032528000421712000992584000618968000289213000283470000322671000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Fulgent Genetics (FLGT) Financials: Revenue & Earnings

FLGT$21.09+0.39 +1.88%

$580.30M

Market Cap

-7.19

P/E

—

Forward P/E

40

Score

Price History